Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.73M | -35.68M | -25.56M | -39.59M | -29.95M |
| Total Depreciation and Amortization | 12.98M | 14.73M | 15.44M | 15.39M | 14.91M |
| Total Amortization of Deferred Charges | -- | 403.00K | 399.00K | 391.00K | -- |
| Total Other Non-Cash Items | 5.25M | 17.21M | -10.25M | 12.41M | 155.00K |
| Change in Net Operating Assets | -5.83M | -19.43M | 4.82M | 1.14M | 5.49M |
| Cash from Operations | 8.67M | -22.77M | -15.15M | -10.27M | -9.39M |
| Capital Expenditure | -4.44M | -2.11M | -2.93M | -2.87M | -4.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -362.00K | -18.63M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -- |
| Cash from Investing | -4.44M | -2.11M | -2.93M | -3.24M | -23.13M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -51.36M | -790.00K | -1.56M | -1.55M | -1.36M |
| Issuance of Common Stock | -- | 4.61M | 111.00K | 13.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.87M | -5.63M | -6.80M | 0.00 | -3.54M |
| Cash from Financing | -55.23M | -1.82M | -8.25M | -1.53M | -4.90M |
| Foreign Exchange rate Adjustments | 30.00K | 14.00K | -8.00K | -111.00K | 73.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.97M | -26.68M | -26.33M | -15.15M | -37.35M |